Anthem ANTM
Quarterly report 2024-Q3
added 10-17-2024
Country |
USA |
IPO year |
- |
Industry |
Health care |
Stock Exchange |
NYSESPB |
CEO |
Ms. Gail Boudreaux |
Employees in the company |
70 600 |
Shares |
236 M |
Market Cap[1] |
$ 107 B |
EBITDA (LTM) |
$ 9.81 B |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Anthem is an American company that provides medical services and health insurance. It was founded in 1940 and is currently one of the largest companies in the industry.
Anthem offers a wide range of medical services, such as preventive check-ups, doctor visits, surgeries, and treatment for various illnesses. The company also provides health insurance for its clients, which helps them receive quality medical care without financial problems.
Anthem actively participates in scientific research in the field of medicine and healthcare, which allows it to provide the most effective and safe medical services for its clients. The company also provides information and consultations on medical issues for its clients.
Anthem has offices and representatives in many countries around the world, which allows it to provide medical services and health insurance for its clients worldwide. The company is a reliable partner for medical institutions and clients who need quality medical care and health insurance.
Other stocks of industry "Health care"
Issuer | Price | % 24h | Market Cap | Exchange | Country | |
---|---|---|---|---|---|---|
Humana
HUM
|
$ 255.29 | -2.08 % | $ 31.6 B | NYSE,SPB | USA | |
Triple-S Management Corporation
GTS
|
$ 35.58 | 0.28 % | $ 847 M | NYSE | USA | |
Magellan Health, Inc.
MGLN
|
$ 94.44 | -0.19 % | $ 2.49 B | Nasdaq Global Select Market,SPB | USA | |
Cigna Corporation
CI
|
$ 311.75 | -1.5 % | $ 91.2 B | NYSE,SPB | USA | |
UnitedHealth Group Inc.
UNH
|
$ 557.24 | -1.82 % | $ 517 B | NYSE,SPB | USA | |
Centene Corporation
CNC
|
$ 64.14 | 0.98 % | $ 34.8 B | NYSE,SPB | USA | |
Molina Healthcare
MOH
|
$ 332.11 | 1.64 % | $ 19.2 B | NYSE,SPB | USA | |
CVS Health Corporation
CVS
|
$ 54.93 | -1.58 % | $ 70.6 B | NYSE,SPB | USA | |
NovoCure Limited
NVCR
|
$ 16.58 | 2.47 % | $ 1.76 B | Nasdaq Global Select Market,SPB | Jersey |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.